MYCHELANGELO
associated with 20 other trademarks
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infect...

Words that describe this trademark:

dna structure  structure  molecules  pharmaceutical  affecting  agents  targeting 

Serial Number:

97438108

Mark:

MYCHELANGELO

Status:

Second Extension-Granted

Status Date:

05-28-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease; therapeutic pharmaceutical agents containing MYC inhibiting properties for the treatment of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

04-04-2023

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

600 ATLANTIC AVENUE

Recent Trademark filings by this company